Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Accumulated Depreciation & Amortization (2017 - 2024)

Historic Accumulated Depreciation & Amortization for Solid Biosciences (SLDB) over the last 8 years, with Q1 2024 value amounting to $13.1 million.

  • Solid Biosciences' Accumulated Depreciation & Amortization rose 2021.74% to $13.1 million in Q1 2024 from the same period last year, while for Mar 2024 it was $13.1 million, marking a year-over-year increase of 2021.74%. This contributed to the annual value of $12.7 million for FY2023, which is 1623.77% up from last year.
  • Solid Biosciences' Accumulated Depreciation & Amortization amounted to $13.1 million in Q1 2024, which was up 2021.74% from $12.7 million recorded in Q4 2023.
  • Over the past 5 years, Solid Biosciences' Accumulated Depreciation & Amortization peaked at $13.1 million during Q2 2022, and registered a low of $5.8 million during Q1 2020.
  • For the 5-year period, Solid Biosciences' Accumulated Depreciation & Amortization averaged around $10.5 million, with its median value being $10.9 million (2021).
  • In the last 5 years, Solid Biosciences' Accumulated Depreciation & Amortization surged by 12511.61% in 2020 and then crashed by 1361.34% in 2022.
  • Quarter analysis of 5 years shows Solid Biosciences' Accumulated Depreciation & Amortization stood at $8.7 million in 2020, then soared by 33.83% to $11.7 million in 2021, then dropped by 6.05% to $11.0 million in 2022, then grew by 16.24% to $12.7 million in 2023, then rose by 2.49% to $13.1 million in 2024.
  • Its Accumulated Depreciation & Amortization stands at $13.1 million for Q1 2024, versus $12.7 million for Q4 2023 and $12.1 million for Q3 2023.